318 related articles for article (PubMed ID: 35022844)
1. Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[
Vaz SC; Adam JA; Delgado Bolton RC; Vera P; van Elmpt W; Herrmann K; Hicks RJ; Lievens Y; Santos A; Schöder H; Dubray B; Visvikis D; Troost EGC; de Geus-Oei LF
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1386-1406. PubMed ID: 35022844
[TBL] [Abstract][Full Text] [Related]
2. Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[
Vaz SC; Adam JA; Delgado Bolton RC; Vera P; van Elmpt W; Herrmann K; Hicks RJ; Lievens Y; Santos A; Schöder H; Dubray B; Visvikis D; Troost EGC; de Geus-Oei LF
Radiother Oncol; 2022 Mar; 168():37-39. PubMed ID: 35066001
[TBL] [Abstract][Full Text] [Related]
3. Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [
Lopci E; Hicks RJ; Dimitrakopoulou-Strauss A; Dercle L; Iravani A; Seban RD; Sachpekidis C; Humbert O; Gheysens O; Glaudemans AWJM; Weber W; Wahl RL; Scott AM; Pandit-Taskar N; Aide N
Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2323-2341. PubMed ID: 35376991
[TBL] [Abstract][Full Text] [Related]
4. EANM/SNMMI practice guideline for [
Adam JA; Loft A; Chargari C; Delgado Bolton RC; Kidd E; Schöder H; Veit-Haibach P; Vogel WV
Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1188-1199. PubMed ID: 33275178
[TBL] [Abstract][Full Text] [Related]
5. SNMMI Procedure Standard/EANM Practice Guideline on Pediatric
Vali R; Alessio A; Balza R; Borgwardt L; Bar-Sever Z; Czachowski M; Jehanno N; Kurch L; Pandit-Taskar N; Parisi M; Piccardo A; Seghers V; Shulkin BL; Zucchetta P; Lim R
J Nucl Med; 2021 Jan; 62(1):99-110. PubMed ID: 33334912
[TBL] [Abstract][Full Text] [Related]
6. Joint EANM-SNMMI guideline on the role of 2-[
Vaz SC; Woll JPP; Cardoso F; Groheux D; Cook GJR; Ulaner GA; Jacene H; Rubio IT; Schoones JW; Peeters MV; Poortmans P; Mann RM; Graff SL; Dibble EH; de Geus-Oei LF
Eur J Nucl Med Mol Imaging; 2024 May; ():. PubMed ID: 38740576
[TBL] [Abstract][Full Text] [Related]
7. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
[TBL] [Abstract][Full Text] [Related]
8. Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [
Lopci E; Aide N; Dimitrakopoulou-Strauss A; Dercle L; Iravani A; Seban RD; Sachpekidis C; Humbert O; Gheysens O; Glaudemans AWJM; Weber WA; Van den Abbeele AD; Wahl RL; Scott AM; Pandit-Taskar N; Hicks RJ
Cancer Imaging; 2022 Dec; 22(1):73. PubMed ID: 36539908
[TBL] [Abstract][Full Text] [Related]
9. Utility of Molecular Imaging with 2-Deoxy-2-[Fluorine-18] Fluoro-DGlucose Positron Emission Tomography (18F-FDG PET) for Small Cell Lung Cancer (SCLC): A Radiation Oncology Perspective.
Sager O; Dincoglan F; Demiral S; Uysal B; Gamsiz H; Elcim Y; Gundem E; Dirican B; Beyzadeoglu M
Curr Radiopharm; 2019; 12(1):4-10. PubMed ID: 30465520
[TBL] [Abstract][Full Text] [Related]
10. Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer.
Gondi V; Bradley K; Mehta M; Howard A; Khuntia D; Ritter M; Tomé W
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):187-95. PubMed ID: 17189070
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Hypermetabolic and Hypoxic Volumes Delineated on [
Thureau S; Modzelewski R; Bohn P; Hapdey S; Gouel P; Dubray B; Vera P
Mol Imaging Biol; 2020 Jun; 22(3):764-771. PubMed ID: 31432388
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric implications of the addition of 18 fluorodeoxyglucose-positron emission tomography in CT-based radiotherapy planning for non-small-cell lung cancer.
Vinod SK; Kumar S; Holloway LC; Shafiq J
J Med Imaging Radiat Oncol; 2010 Apr; 54(2):152-60. PubMed ID: 20518880
[TBL] [Abstract][Full Text] [Related]
13. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives.
Nestle U; Kremp S; Grosu AL
Radiother Oncol; 2006 Nov; 81(2):209-25. PubMed ID: 17064802
[TBL] [Abstract][Full Text] [Related]
14. Correction to: Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[
Vaz SC; Adam JA; Delgado Bolton RC; Vera P; van Elmpt W; Herrmann K; Hicks RJ; Lievens Y; Santos A; Schöder H; Dubray B; Visvikis D; Troost EGC; de Geus-Oei LF
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(9):3300-3301. PubMed ID: 35482115
[No Abstract] [Full Text] [Related]
15. Assessment of tumour response after stereotactic ablative radiation therapy for lung cancer: A prospective quantitative hybrid
Yang DM; Palma D; Louie A; Malthaner R; Fortin D; Rodrigues G; Yaremko B; Laba J; Gaede S; Warner A; Inculet R; Lee TY
J Med Imaging Radiat Oncol; 2019 Feb; 63(1):94-101. PubMed ID: 30281918
[TBL] [Abstract][Full Text] [Related]
16. Use of PET/CT for staging and radiation therapy planning in patients with non-small cell lung cancer.
Mac Manus MP
Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):510-20. PubMed ID: 20927018
[TBL] [Abstract][Full Text] [Related]
17. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242
[TBL] [Abstract][Full Text] [Related]
18. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
[TBL] [Abstract][Full Text] [Related]
19. A new method to assess pulmonary changes using
Abravan A; Knudtsen IS; Eide HA; Løndalen AM; Helland Å; van Luijk P; Malinen E
Acta Oncol; 2017 Nov; 56(11):1597-1603. PubMed ID: 28849707
[TBL] [Abstract][Full Text] [Related]
20. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
Nestle U; Kremp S; Schaefer-Schuler A; Sebastian-Welsch C; Hellwig D; Rübe C; Kirsch CM
J Nucl Med; 2005 Aug; 46(8):1342-8. PubMed ID: 16085592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
